Yang, Yang
Wang, Lili
Bell, Peter
McMenamin, Deirdre
He, Zhenning
White, John
Yu, Hongwei
Xu, Chenyu
Morizono, Hiroki
Musunuru, Kiran
Batshaw, Mark L
Wilson, James M
Article History
Received: 23 September 2015
Accepted: 30 December 2015
First Online: 1 February 2016
Competing interests
: J.M. Wilson is an advisor to REGENXBIO, Dimension Therapeutics and Solid Gene Therapy, and is a founder of, holds equity in, and has a sponsored research agreement with REGENXBIO and Dimension Therapeutics; in addition, he is a consultant to several biopharmaceutical companies and is an inventor on patents licensed to various biopharmaceutical companies.